Skip to content

Capillary rarefaction in chronic kidney disease (CKD) (Cap-CKD): A survey on microvasculature and renal function in patients undergoing a nephrectomy

Capillary rarefaction in chronic kidney disease (CKD) (Cap-CKD): A survey on microvasculature and renal function in patients undergoing a nephrectomy - Capillary rarefaction in chronic kidney disease (CKD): Cap-CKD

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46422
Enrollment
281
Registered
2018-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney failure

Interventions

None listed

Sponsors

Pathologie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who undergo a nephrectomy for a suspected renal cell carcinoma and who are 18 years or older and are able to read and write.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Primary Objective: The primary objective of the study is to assess the relationship between renal PTC density and renal function before and two years after surgery.

Secondary

MeasureTime frame
Secondary Objectives: The secondary objectives of the study are to assess a) the relationship between renal PTC density and systemic capillary density and microvascular function in patients with and without CKD at nephrectomy and after two years. b) the relationship between renal PTC density and histological and molecular damage (e.g. IF/TA, inflammation, angiogenic profiling, MSI) in renal tissue in patients with and without CKD at nephrectomy and after two years. c) the relationship between renal PTC density and renal function in relation to known cardiovascular risk factors such as demographic variables (age, gender), clinical variables (renal function, hypertension. glucose intolerance, mineral metabolism, BMI), and medical history (smoking history, medication use, birth weight).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)